Position in RXST
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$1,909,600
-$1,216,400 QoQ
Shares Held
310,000
+3.3% QoQ
Ownership
0.749%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RXST Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026TOCQUEVILLE ASSET MANAGEMENT L.P. holds $143,832,785 across 15 Medical Devices names. RXST ranks #11 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BSX |
Boston Scientific Corp
|
678,172 | $42,555,293 | |
| 2 | GEHC |
GE HealthCare Technologies Inc.
|
359,492 | $25,588,640 | |
| 3 | ABT |
Abbott Laboratories
|
210,484 | $21,610,392 | |
| 4 | MDT |
Medtronic plc
|
170,833 | $14,802,679 | |
| 5 | AXGN |
Axogen, Inc.
|
384,900 | $12,751,737 | |
| 6 | SNN |
Smith & Nephew PLC
|
208,997 | $6,641,924 | |
| 7 | EW |
Edwards Lifesciences Corp
|
61,115 | $4,894,089 | |
| 8 | VMD |
Viemed Healthcare, Inc.
|
472,100 | $4,348,041 |
All Filings in RXST
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,909,600 | 310,000 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $3,126,000 | 300,000 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $2,697,000 | 300,000 | Shares | Sole | 2025-11-13 | |
| No filing history on record for this holder in this stock. | ||||||